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Background: While most people faced with a terminal illness would prefer to die at home, less than a third in
England are enabled to do so with many dying in National Health Service hospitals. Patients are more likely to die
at home if their carers receive professional support. Hospice rapid response teams, which provide specialist
palliative care at home on a 24/7 on-call basis, are proposed as an effective way to help terminally ill patients die in
their preferred place, usually at home. However, the effectiveness of rapid response teams has not been rigorously
evaluated in terms of patient, carer and cost outcomes.
Methods/Design: The study is a pragmatic quasi-experimental controlled trial. The primary outcome for the
quantitative evaluation for patients is dying in their preferred place of death. Carers’ quality of life will be evaluated
using postal questionnaires sent at patient intake to the hospice service and eight months later. Carers’ perceptions
of care received and the patient’s death will be assessed in one to one interviews at 6 to 8 months post
bereavement. Service utilisation costs including the rapid response intervention will be compared to those of
usual care.
Discussion: The study will contribute to the development of the evidence base on outcomes for patients and
carers and costs of hospice rapid response teams operating in the community.
Trial registration: Current controlled trials ISRCTN32119670.
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While most people faced with a terminal illness would
prefer to die at home [1,2], less than a third in England
are enabled to do so with many dying in National Health
Service (NHS) hospitals [2,3]. Given ideal circumstances,
two thirds of terminally ill people would wish to die at
home [2]. Many dying patients do not have effective
choice over where they die. When professional support
at home is available patients are more likely to die there
[4,5]. The Department of Health policy guidance [6]
stresses the importance of helping patients to achieve
their wishes for place of death and the potential contri-
bution of rapid response services to this cause.
Patients with life limiting conditions are often admit-
ted to hospital because of a crisis or challenge that could* Correspondence: L.M.Holdsworth@kent.ac.uk
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reproduction in any medium, provided the ornot be resolved at home [7]. The crisis often stems from
uncontrolled symptoms, carer fear or stress, not having
medication available, or not having enough information
about the patient’s prognosis or disease trajectory [7].
Research has shown that patients who spend more time
in hospital or hospice during their illness are more likely
to die there [5], therefore keeping patients out of in-
patient facilities may help improve the likelihood that
patients will be able to die at home. Rapid response
teams providing palliative care respond quickly to crises
and emergencies to help patients avoid admission to
hospice or hospital. They integrate with routine commu-
nity care and withdraw after the crisis has resolved,
which may be death. They provide intense care for a few
days at a time and operate on a 24/7 on-call basis. They
are available at a time when the patient and/or carer are
most vulnerable and when no other service is available
or able to manage the crisis.
The effectiveness of rapid response teams has not been
rigorously evaluated and there have been only threetd. This is an Open Access article distributed under the terms of the Creative
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evaluations, lacking control groups and two had small
sample sizes (17 patients and 62 patients). The studies
all identified above national average (21%) number of
patients dying at home [3], 42%, 41% and 29%, and
below national average use of institutional care. Thus
rapid response services appear to prevent crisis admis-
sions and increase the number of patients able to die
at home, though these evaluations lack the power to
provide an adequate evidence base without a control
group.
It is important to evaluate new palliative care services
in terms of patients’ preferences and service delivery
costs, but it is also important to consider the impact of
care in terms of carers’ quality of life and experiences.
The Department of Health in the End of Life Care Strat-
egy [6] discusses the concept of a good death and identi-
fies key elements of the dying persons' experience,
including dignity and respect, effective pain manage-
ment, familiar surroundings and presence of family and
friends. However it is not clear what factors are key to
carers’ experiences.
The aim of the study is to contribute to the develop-
ment of the evidence base on the consequences and
costs of hospice rapid response teams, compared to
usual care. It will also contribute to an understanding
of the ways in which carers’ perceive and evaluate a
‘good death’.Hypotheses
The primary hypothesis, stated as a null hypothesis, is
that rapid response services will lead to similar numbers
of patients dying in their preferred place of death as is
achieved with usual care. Secondary hypotheses address
whether the rapid response service affects the quality of
life of carers and whether there are cost savings from
the rapid response service compared with usual care. In
addition we aim to conduct a qualitative study to explore
how carers perceive the quality of care and judge a ‘good
death’.Area 3 
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Figure 1 Time of service delivery by area.Methods/Design
Study design
The quantitative evaluation of the rapid response inter-
vention is a pragmatic quasi-experimental multi-centre
controlled trial, with an embedded cost evaluation. The
study also includes a qualitative evaluation using in-
depth interviews to explore carers’ perceptions.
Setting
The study is based at Pilgrims Hospices in East Kent which
serves a community of 600,000 through three centres
based in Canterbury, Ashford and Margate. The hospices
each have an inpatient ward with 16 beds, a community
outreach service and a day hospice. It receives approxi-
mately 2,000 referrals each year.
Randomisation
The rapid response service will be rolled out sequentially in
the three centres with six months between the start of
provision in each site (Figure 1). A simple probabilistic ran-
domisation method will be used to determine the order in
which the three areas start the rapid response service. Once
the intervention is introduced in an area, it will be available
to all patients within the catchment area of that hospice,
while usual services will continue to be offered in the con-
trol areas until the new service is rolled out in that area.
The evaluation design randomises centres and there-
fore does not require the blind randomisation of individ-
ual patients into intervention or control group which
would create serious ethical and practical problems. It is
a design that protects from a number of potential sources
of bias: contamination between patients, changes in
health policy over time and resentful demoralisation of
patients [11]. The design simultaneously addresses the
situational and resource factors that arise from imple-
menting an intensive new service across a wide area.
Intervention
The rapid response service has been developed in line
with best practice and following a complete literatureRapid response service + 
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rapid response services [12]. The main features of the
service are that it:
 Is available to patients in their own home (including
care homes);
 Has a robust ‘hospice standard’ assessment which
takes account of: patient preferences, carer/family
preferences, patient needs, and patient prognosis;
 Provides hands on care;
 Responds rapidly to crises using human and material
resources available 24/7 with access to health care
assistants, service coordinator, palliative care
nursing, medical advice, and small pieces of
equipment which can be carried by car; and
 Works in coordination with other community
services.
Patient evaluation
Inclusion criteria
All new referrals to the hospice who are assessed by a
member of the hospice team during the study period are
potentially eligible for inclusion in the study and may re-
ceive the intervention if available in their area. However,
as the primary outcome measure is achieving the pre-
ferred place of death only those referred who die within
the intervention or control period will be included in the
analysis.Main carer identified 
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Figure 2 Patient and carer data collection flow chart for both interveSample size
The primary outcome measure for the patient evaluation
is death in the first recorded preferred place of death. In
current 'usual' service provided by Pilgrims Hospices,
approximately 29% of patients die in their preferred
place of death. Increasing this figure to 60% will be
equivalent to the gold standard framework for end of life
care. In order to detect a difference of this magnitude,
with alpha at 0.05 and 90% power, using a 2-sided test,
requires data to be collected on 49 new patients per site
per six month period. The design of the study involves 9
cells (Figure 1) so the total sample size is inflated to 441.
This equates to 147 for each of the three sites and 147
for each six monthly period.
Clinical outcomes
Preferences and any changes in preference will be ascer-
tained by hospice nurses or doctors undertaking com-
munity, inpatient or clinic based assessments. Actual
place of death will also be recorded.
Data collection
Data collection for the patient outcome will be con-
ducted in a two stage process (Figure 2). First, patients
will be entered onto a database after they have had their
first assessment with a member of the hospice team. It is
at this point that carers will be sent a questionnaire. Pa-
tient preferences will then be monitored while underPatient 
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baseline 
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*If baseline questionnaire returned and 
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ences over time. At the end of the study period, any
patients still alive will be excluded as well as their carer.
Patients who have died during the study period and who
had a preferred place of death recorded in the hospice
notes will be included. At this point, these patients’ pre-
ference data, place of death, diagnosis, demographic data
and service utilisation data will be extracted from service
records. Patients who died during the study period but
did not have a preferred place of death recorded will be
excluded from analysis, but carers of this group will be
included.
Data analysis
The main hypothesis will be tested using logistic regres-
sion controlling for baseline values and cluster using
robust standard errors. Achieving preferred place of
death will be presented as odds ratios, for control and
intervention periods with associated 95% confidence
intervals. A secondary analysis will explore last stated
preferred place of death versus actual place of death
using a similar approach.
Economic evaluation for patients
A critical aspect of an evaluation such as this is to in-
clude a measure of impact from an economic perspective
particularly one that could be utilised by commissioners
to make decisions regarding the relative economic im-
pact of an intervention. The costs of the intervention will
be calculated on an individual patient basis. Staff time in-
put, mileage travelled to patient homes and consumables
used in the delivery of the rapid response intervention
will be obtained from the service’s activity logs and pa-
tient records. Resource utilisation will be converted to
costs using nationally validated unit costs, for staff time
[13], and information from local financial managers for
expenditure on travel and consumable items. The overall
service utilisation of all participants during the time they
are in the study will be collected for all patients in both
arms including: general practice and community
resources, outpatient, inpatient stays, out of hours ser-
vice, Marie Curie nurse visits, and social care packages.
This information will be gathered from providers’ data-
bases for the period that each patient is in the study, and
converted to unit costs [13]. The extent to which the
rapid response service substitutes for other forms of
health and social care (both community-based and in-
patient) will be assessed.
The difference between the mean cost of patients in
the rapid response arm and patients receiving treatment
as usual will be calculated and compared with the differ-
ence between groups in the primary effectiveness out-
come (proportion dying in preferred place of death). If
the hospice intervention results in significantly improvedoutcomes at lower cost, it becomes the service delivery
option of choice. If the intervention achieves superior
outcomes (significantly more patients dying in their pre-
ferred place), but at higher cost, the cost per percentage
point gain in dying in the preferred place will be
calculated.
Carer evaluation
Carers will be included in the study if they cared for a
patient who died within the study period. Only one main
carer per patient will be sampled.
Sample size
The primary outcome measure for the carer evaluation
is quality of life, measured using SF12 [14], at patient in-
take to hospice services and 8 months later. A clinically
important change for quality of life is estimated as a 5
point change on the SF12. This equates to a medium ef-
fect size difference between the groups of 0.5. In order
to establish an effect size difference of this magnitude at
80% power, with alpha at 0.05 requires 56 people within
each of the intervention and control cells of the study.
Previous experience with similar populations suggests
50% will refuse consent and the follow up rate at
8 months will be of the order of 70%. This inflates the
required sample of potential carers to 160 in each cell of
the study design, a total of 1440. Assuming that 40% of
end of life patients have no primary carer the numbers
seen over the study period based on current referral
rates allow for a potential recruitment population of
1800.
Outcomes for carers
Carer outcomes will be measured at baseline on patient
intake and 8 months later using self completion postal
questionnaires. The primary outcome measure will be
the short-form SF12 [14]. Other outcomes include a
measure of anxiety and depression (HADS) [15], a meas-
ure of health utility (EQ-5D) [16], and caregiving de-
mand [17] measured at baseline only. In the follow-up
questionnaire a satisfaction with care questionnaire will
be included.
Data analysis
Prior to the analysis of outcomes distributional assump-
tions will be checked and the analytical framework
adjusted to account for these. Analysis of quality of life
will be conducted using analysis of covariance, or non-
parametric equivalent, adjusting for baseline values and
carer burden. Potential cluster effects will be explored
using robust standard errors. A similar approach will be
employed for other carer outcomes. Results will be
presented as means per group and appropriate esti-
mates of precision.
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In our review of the evidence we were unable to locate
an established and agreed way of assessing carers’ per-
ception of a good death and the experiences of the dying
process. This study provides a unique opportunity to ex-
plore this issue with carer respondents.
Sample and access
Approximately 6 to 8 months after death invitations to
participate in an interview will be sent to select bereaved
carers of patients who expressed a preferred place of
death. Given the exploratory nature of these interviews,
a purposive sample is appropriate. In order to include a
range of views, we will aim to recruit up to 60 bereaved
carers from both intervention and control arms and
carers of patients who both achieved their preferred
place of death and those who did not.
Interviews
Interviews will be conducted using a semi-structured
topic guide which will allow the researcher to cover a
range of topic areas but with some flexibility so that the
respondent is free to discuss and explain their own
views, experiences and feelings [18]. The intention is to
elicit complex, in-depth data in relation to end of life
care. Interviews will take place at a time and place con-
venient to the respondent and will be designed to last up
to an hour.
Data analysis
Interviews will be recorded (if the respondent agrees)
and transcribed. Analysis will follow the framework
method [19], which is a matrix based thematic analytic
method in which the links between the ‘raw’ data and
different levels of abstraction are maintained through
transparent data management. A purposive sample of
this nature will enable a thematic analysis and identify
the range of respondent experiences. There should also
be ample data to undertake a comparative analysis for
the intervention and control group carers, and between
those whose relatives died in their preferred setting and
those who did not. Analytical rigour will be maintained
by using a second researcher to code a proportion of the
transcripts to test for reliability within the coding
framework.
Ethical approval
Ethical approval was granted by Kent Research Ethics
Committee, reference 09/H1101/75. The study will be
conducted in accordance with the Helsinki declaration.
Discussion
The collection and recording of the patient’s preferred
place of death was regarded as a routine clinical activity.Early in the study, an intervention designed to assist and
encourage staff with this data collection was planned
through meetings between the research team and clinical
staff.
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